Kevin Kim, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Mirdametinib in Patients With Advanced NF1-mutant Melanoma (NCT07237100) | Kevin Kim, MD | 2025-10-13 |
Track Kevin Kim, MD automatically
Every clearance here is in the API, with alerts when new ones post.